MK0869 (0869-060)

MK0869 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0869 (0869-060), covering 2015-02-09 to 2015-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED) [Phase 3]